EUVIMEDEUVIMED entdecken
Crossref

Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axis

Chao Zhang, Zonghao Pan, Xuli Ma, Daidi Zhao, Xu Yan, Yan Jia, Kaixi Ren, Jiaqi Ding, Yao Wang, Hongzeng Li, Jun Guo

Clinical Immunology · 2026-04 · 284 · 110682

DOI: 10.1016/j.clim.2026.110682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2026-04. Verfasst von Chao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Neuromyelitis Optica, Receptors, Immunologic, Myeloid-Derived Suppressor Cells. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells and myeloid-derived suppressor cells (MDSCs) are implicated in neuromyelitis optica spectrum disorder (NMOSD), but their potential interplay remains unclear. In this study, we identified an increased frequency of polymorphonuclear MDSCs (PMN-MDSCs) and a decreased frequency of NK cells in NMOSD patients. In patients during remission, CD155 expression on PMN-MDSCs and TIGIT expression on NK cells were elevated, while NK cell activating receptors NKp30 and NKp46 were downregulated. The Expanded Disability Status Scale score correlated positively with MDSC and NKp46+ NK cell frequencies, but negatively with TIGIT+ NK cells. In vitro, PMN-MDSCs suppressed NK cell function through both soluble mediators and the contact-dependent CD155/TIGIT axis, as evidenced by reduced IFN-γ secretion and receptor modulation. This suppression was reversed by blocking CD155 or TIGIT. These findings suggest that PMN-MDSCs could inhibit NK cell function in NMOSD potentially via the CD155/TIGIT axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalNeuromyelitis OpticaReceptors, ImmunologicMyeloid-Derived Suppressor CellsReceptors, VirusHumansFemaleAdultMaleMiddle AgedNatural Cytotoxicity Triggering Receptor 1Natural Cytotoxicity Triggering Receptor 3Interferon-gamma

Stichwörter der Autor:innen

CD155/TIGIT axisMyeloid-derived suppressor cellNatural killer cellNeuromyelitis optica spectrum disorder

Substanzen

Receptors, Immunologicpoliovirus receptorReceptors, VirusTIGIT protein, humanNatural Cytotoxicity Triggering Receptor 1Natural Cytotoxicity Triggering Receptor 3NCR3 protein, humanNCR1 protein, humanInterferon-gamma

Autor:innen und Institutionen

  • Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. Electronic address: guojun_81@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, C., Pan, Z., Ma, X., Zhao, D., Yan, X., Jia, Y., Ren, K., Ding, J., Wang, Y., Li, H., & Guo, J. (2026). Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axis. Clinical Immunology, 284, 110682. https://doi.org/10.1016/j.clim.2026.110682

Vancouver

Zhang C, Pan Z, Ma X, Zhao D, Yan X, Jia Y, et al. Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axis. Clinical Immunology. 2026;284:110682. doi:10.1016/j.clim.2026.110682

BibTeX
@article{Zhang2026,
  author = {Zhang, Chao and Pan, Zonghao and Ma, Xuli and Zhao, Daidi and Yan, Xu and Jia, Yan and Ren, Kaixi and Ding, Jiaqi and Wang, Yao and Li, Hongzeng and Guo, Jun},
  title = {Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axis},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {284},
  pages = {110682},
  doi = {10.1016/j.clim.2026.110682}
}
Kostenlos starten →